Literature DB >> 26288671

Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications.

Cumara B O'Carroll1, Maria I Aguilar1.   

Abstract

Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.

Entities:  

Keywords:  cerebrovascular disorders; clinical specialty; intracranial hemorrhages; neurohospitalist; stroke

Year:  2015        PMID： 26288671      PMCID： PMC4530424          DOI： 10.1177/1941874415587680

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN： 1941-8744


  64 in total

1.  Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator.

Authors:  K F French; Jacob White; R E Hoesch
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

2.  Treatment of acute intracerebral hemorrhage with epsilon-aminocaproic acid: a pilot study.

Authors:  Paisith Piriyawat; Lewis B Morgenstern; David H Yawn; Christiana E Hall; James C Grotta
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

4.  Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase Clinical Trial II (J-ACT II).

Authors:  Etsuro Mori; Kazuo Minematsu; Jyoji Nakagawara; Takenori Yamaguchi; Makoto Sasaki; Teruyuki Hirano
Journal:  Stroke       Date:  2010-01-14       Impact factor: 7.914

5.  Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage.

Authors:  Georgios Tsivgoulis; James L Frey; Murray Flaster; Vijay K Sharma; Annabelle Y Lao; Steven L Hoover; Wei Liu; Elefterios Stamboulis; Anne W Alexandrov; Marc D Malkoff; Andrei V Alexandrov
Journal:  Stroke       Date:  2009-09-17       Impact factor: 7.914

6.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

7.  Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.

Authors:  M D Hill; T Lye; H Moss; P A Barber; A M Demchuk; N J Newcommon; T L Green; C Kenney; A Cole-Haskayne; A M Buchan
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

8.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

Review 9.  Intracerebral hemorrhage.

Authors:  Maria I Aguilar; Bart M Demaerschalk
Journal:  Semin Neurol       Date:  2007-09       Impact factor: 3.420

10.  Onset of Orolingual Angioedema After Treatment of Acute Brain Ischemia with Alteplase Depends on the Site of Brain Ischemia: A Meta-analysis.

Authors:  Josef Yayan
Journal:  N Am J Med Sci       Date:  2013-10
View more
  10 in total

Review 1.  Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease.

Authors:  Madhumitha Katta; Blessy Aksa Mathew; Pragya Chaturvedi; Abhilash Ludhiadch; Anjana Munshi
Journal:  Neurol Sci       Date:  2022-09-06       Impact factor: 3.830

Review 2.  Structural and Pharmacological Network Analysis of miRNAs Involved in Acute Ischemic Stroke: A Systematic Review.

Authors:  Oscar Salvador Barrera-Vázquez; Juan Carlos Gomez-Verjan; Ricardo Ramírez-Aldana; Paola García-Dela Torre; Nadia Alejandra Rivero-Segura
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

3.  Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction.

Authors:  Fariborz Khorvash; Fatemeh Heidary; Mohammad Saadatnia; Ahmad Chitsaz; Zahra Tolou-Ghamari
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852

4.  A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy.

Authors:  Mohamed Shirazy; Anis Chaari; Karim Hakim; Kamel Bousselmi; Vipin Kauts
Journal:  Drug Saf Case Rep       Date:  2019-10-11

Review 5.  Asthma and stroke: a narrative review.

Authors:  A Corlateanu; Iu Stratan; S Covantev; V Botnaru; O Corlateanu; N Siafakas
Journal:  Asthma Res Pract       Date:  2021-02-19

Review 6.  Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review.

Authors:  Annie Zhu; Phavalan Rajendram; Eric Tseng; Shelagh B Coutts; Amy Y X Yu
Journal:  Res Pract Thromb Haemost       Date:  2022-09-20

7.  LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.

Authors:  Be'eri Niego; Brad R S Broughton; Heidi Ho; Christopher G Sobey; Robert L Medcalf
Journal:  Fluids Barriers CNS       Date:  2017-11-21

8.  A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration.

Authors:  Dustin Harris; David Harter
Journal:  Cureus       Date:  2018-06-23

9.  Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator.

Authors:  Vijay Chenna; Subhash Kaul; Swetha Tandra; Sireesha Yareeda; Neeharika Mathukumalli; Abhijeet Kumar Kohat; Rukmini Mridula Kandadai; Suryaprabha Turaga; Jabeen Afshan Sheik; A K Meena; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2018 Jul-Sep       Impact factor: 1.383

10.  Endothelial progenitor cells, potential biomarkers for diagnosis and prognosis of ischemic stroke: protocol for an observational case-control study.

Authors:  Kamini Rakkar; Othman Othman; Nikola Sprigg; Philip Bath; Ulvi Bayraktutan
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.